irinotecan has been researched along with torpedo in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brumshtein, B; Harel, M; Hyatt, JL; Morton, CL; Potter, PM; Silman, I; Sussman, JL; Wadkins, RM; Yoon, KJ | 1 |
| Brumshtein, B; Harel, M; Hyatt, JL; Morton, CL; Potter, PM; Silman, I; Sussman, JL; Wadkins, RM | 1 |
2 other study(ies) available for irinotecan and torpedo
| Article | Year |
|---|---|
The crystal structure of the complex of the anticancer prodrug 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11) with Torpedo californica acetylcholinesterase provides a molecular explanation for its cholinergic action.
Topics: Acetylcholinesterase; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Cholinesterase Inhibitors; Crystallization; Crystallography, X-Ray; Humans; Irinotecan; Prodrugs; Torpedo | 2005 |
The 3D structure of the anticancer prodrug CPT-11 with Torpedo californica acetylcholinesterase rationalizes its inhibitory action on AChE and its hydrolysis by butyrylcholinesterase and carboxylesterase.
Topics: Acetylcholinesterase; Animals; Antineoplastic Agents; Butyrylcholinesterase; Camptothecin; Carboxylesterase; Cholinesterase Inhibitors; Crystallography, X-Ray; Hydrolysis; Irinotecan; Liver; Models, Molecular; Protein Structure, Tertiary; Rabbits; Torpedo | 2005 |